A study on drug diffusion of anterior quadratus lumborum block at the supra-arcuate ligament under CT

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300072811

Enrollment

Unknown

Registered

2023-06-26

Start date

2023-07-01

Completion date

Unknown

Last updated

2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

A(experimental group):Ultrasound guided bilateral anterior quadratus lumborum block at the supra-arcuate ligament

M (control group):Ultrasound guided bilateral transmuscular quadratus lumborum block

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.ASA classification: Level I-III 2.BMI:18–30kg/m2 3.Patients with primary or secondary hepatic carcinoma undergoing CT guided microwave ablation

Exclusion criteria

Exclusion criteria: 1.Preoperative neurological, psychiatric, and cognitive impairment 2.Severe cardiovascular, cerebrovascular, and blood diseases 3.Oral analgesics 4.Abnormal coagulation function 5.Allergies to local anesthetics and contrast agents 6.Local or systemic infection at the puncture site

Design outcomes

Primary

Measure	Time frame
Number of vertebral segments where the contrast agent diffuses towards the head and tai;	—

Secondary

Measure	Time frame
Dermatomal blockade range;Intraoperative VAS score;Postoperative 2h VAS score;Postoperative 12h VAS score;Postoperative 24h VAS score;Intraoperative dosage of propofol;	—

Countries

China

Contacts

Public ContactJiang Zhu

Department of Anesthesiology, Second Affiliated Hospital of Soochow University Department of Anesthesiology, Second Affiliated Hospital of Soochow University

zhujiangsz@126.com+86 139 6215 3438

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026